Companies: 10,795·Total market cap: $144.5T
Aurora Cannabis Inc.

Aurora Cannabis Inc.

ACBNASDAQHealthcare● Active
$3.41
+$0.03(+0.89%)
Market Cap$201621720
P/E Ratio
52W High$6.665
52W Low$3.07

Aurora Cannabis Inc. (ACB) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ACB · free cash flow · updated Jun 9, 2026

Core FCF metrics

Free cash flow was −$2.9M for FY2025 (fiscal year ending 2025-03-31), up 96.7% year-over-year The FCF margin was -0.8%.

FY2025 Free Cash Flow−$2.9M▲ +96.7% YoY
Trailing 12M (TTM)−$31.3Mtrailing 4 quarters sum
FCF Margin-0.8%−$2.9M ÷ revenue
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
acb free cash flow history · acb free cash flow chart · acb free cash flow growth rate · acb free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest−$2.9M▲ +96.7%-0.8%
FY2024−$85.3M▲ +33.3%-31.6%
FY2023−$128.0M▲ +10.2%-57.2%
FY2022−$142.5M▲ +46.0%-64.4%
FY2021−$263.7M▲ +61.8%-107.5%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
acb free cash flow 2025 · acb free cash flow 2024 · acb free cash flow 2023 · acb operating cash flow

FCF valuation metrics

Aurora Cannabis Inc. (ACB) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-03-31
acb price to free cash flow · acb free cash flow yield · acb free cash flow per share · acb price to cash flow ratio

Cash flow statement summary

For FY2025, Aurora Cannabis Inc. generated $16.0M in operating cash flow and spent 19M in capital expenditures, yielding −$2.9M in free cash flow.

Operating Activities
+$16.0M
Cash from core business operations
2025-03-31
Investing Activities
−$14.3M
CapEx, acquisitions & investments
2025-03-31
Financing Activities
−$0.1M
Buybacks, dividends & debt
2025-03-31
FCF FormulaOperating CF ($16.0M) − |CapEx| (19M) = FCF (−$2.9M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
acb cash flow statement · acb cash flow statement 2025 · acb operating cash flow · acb cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Aurora Cannabis Inc.
Aurora Cannabis Inc.YOU
ACB
−$2.9M+96.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Aurora Cannabis Inc. (ACB) reported free cash flow of −$2.9M for FY2025 (fiscal year ending 2025-03-31), up 96.7% year-over-year. The FCF margin was -0.8%.

Aurora Cannabis Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

ACB free cash flow · 8 questions

Aurora Cannabis Inc. free cash flow was −$2.9M for FY2025, up 96.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$31.3M.

ACB free cash flowACB FCFACB FCF 2025ACB free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Aurora Cannabis Inc. · Aurora Cannabis Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026